ENTITY
Luye Pharma

Luye Pharma (2186 HK)

97
Analysis
Health CareChina
Luye Pharma Group Ltd focuses on the research and development, production, and sales of pharmaceutical drugs for orthopedics, neurology, gastroenterology, and hepatology. The Company also sells active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis.
more
18 Oct 2024 23:12

China Traditional Chinese Medicine (570 HK): Disaster as Offer Lapses, Potential Deal Break Price

This deal break caught many, including me, off guard. There are lessons to be learnt and questions to be asked. Shareholders will have a bruising...

Logo
1k Views
Share
17 Oct 2024 00:34

China Traditional Chinese Medicine (570 HK): Theatre of the Absurd

The update will do little to soothe frayed nerves. The extension will be forthcoming as the delay is procedural, there is a reputational risk from...

Logo
610 Views
Share
09 Oct 2024 14:13

China Traditional Chinese Medicine (570 HK): Never a Dull Moment as Profit Warning Lands

According to the Beijing Municipal Government website, China TCM has received unconditional approval from SAMR. This news was largely expected and...

Logo
992 Views
Share
30 Sep 2024 07:22

Technically Speaking, Breakouts and Breakdowns: HONG KONG (SEPTEMBER 30)

Hong Kong dollar strengthens to the strong end of the band.  Hengan and Galaxy share prices have both broken out of Falling Wedge patterns.  Wuxi...

Logo
132 Views
Share
08 Sep 2024 10:05

Hong Kong Connect Flows (Sep 6th): Inflows into ETF, Li Auto, Tencent

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for HSI ETF (2800 HK), HSCEI ETF (2828 HK), Li Auto (2015...

Logo
381 Views
Share
x